順發恆業(000631.SZ):萬向集團公司申請豁免要約收購義務獲中證監核准
格隆匯1月7日丨順發恆業(000631.SZ)公佈,2020年1月7日,公司收到萬向集團公司轉來的中國證監會《關於核准豁免萬向集團公司要約收購順發恆業股份公司義務的批覆》(證監許可[2019]2991號),核准豁免因協議轉讓而持有順發恆業股份公司的約14.9183億股股份,約佔該公司總股本的61.33%而應履行的要約收購義務。
上述事項完成後,公司的控股股東為萬向集團公司,實際控制人仍是魯偉鼎。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.